HARCP

HEROIN ADDICTION AND
RELATED CLINICAL PROBLEMS

The official journal of
EUROPAD - European Opiate Addiction Treatment Association
WFTOD - World Federation for the Treatment of Opioid Dependence
Editor: Icro Maremmani, MD - Pisa, Italy, EU
Associate Editors:
Thomas Clausen, MD - Oslo, Norway
Pier Paolo Pani, MD - Cagliari, Italy, EU
Marta Torrens, MD - Barcelona, Spain, EU

HARCP Archives

Browse by volume Browse by article Published Ahead
of Print
 

 

 

If you want to download the journal, please login or register as reader.

2009 Issues

Cover

Vol. 11 • No. 1 • March 2009

In this issue:

  • Treatment of Opioid Dependence and ADHD/ADD with Opioid Maintenance and Central Stimulants
    Blix O., Dalteg A., Nilsson P.
  • Dihydrocodeine for the Treatment of Alcohol Dependence
    Ulmer A., Müller M., Frietsch B.
  • Use and Abuse of High-Dose Buprenorphine (HDB) Obtained Without a Prescription: a French Survey
    Courty P.
  • A 10-Year Evaluation of Chronic Pain Patients Treated with Opioids
    Tennant F.
  • Psychotherapeutic Experiences with Methadone Maintained Patients in the Framework of Multidisciplinary Clinical Institution
    Todorov O.
  • Preferences for Buprenorphine/Naloxone (Suboxone®) and Buprenorphine (Subutex®) in Patients Receiving Buprenorphine Maintenance Therapy in France: A Prospective, Multicentre Study
    Daulouède J.-P., Caer Y., Galland P., Villeger P., Brunelle E., Bachellier J., Piquet J.-M., Harbonnier J., Leglise Y., Courty P.
  • Coordinating Methadone Treatment Providers and Policymakers: Lessons Learned Over 30 Years
    Parrino M. W.
  • En Route to 90% Retention. ‘Active Rehabilitation' in Central Norway
    Nordstrand B.

 

Cover

Vol. 11 • No. 2 • June 2009

In this issue:

  • Swedish Use and Misuse of the Dole & Nyswander Treatment
    Gunne L.
  • Methadone-treated Patients After Switching to Buprenorphine in Residential Therapeutic Communities: An Addiction-specific Assessment of Quality of Life
    González-Saiz F., Gómez R. B., Bilbao Acedos I., Lozano Rojas O., Gutiérrez Ortega J.
  • Clinical trial on the use of olanzapine in reducing the consumption of cocaine in Methadone Maintenance Programmes
    Vázquez M. L., Castillo I. I., Jiménez-Lerma J. M., Beldarrain J. A. H., Gutiérrez-Fraile M.
  • Voices of Experience: Attitudes and Opinions of Recipients of Unsupervised Injectable Opiate Treatment in the Northwest of England
    Orgel M., Wilson A., Leavey R., Sell L., Zador D.
  • Substitution Therapy. A New Problem of Biomedical Ethics and Medical Law
    Mendelevich V. D.
  • New Approaches in the Treatment of Opioid Dependency During the Pregnancy
    Finnegan L., Winklbaur B., Fischer G., May O., Welle-Strand G.
  • QTc Interval Screening. American Association for the Treatment of Opioid Dependance (AATOD) Policy and Guidance Statement
    Parrino M., Aatod Board of Directors

 

Cover

Vol. 11 • No. 3 • September 2009

In this issue:

  • Methadone Treatment in Italy in the Third Millennium: Continuing Fear of Treatment
    Maremmani I.
  • Pharmacology and Neurochemistry of Methadone
    Vendramin A., Sciacchitano A. M.
  • Cannabis and Premonitory Symptoms of Schizophrenia: What Is the Time Sequence?
    Vernex N., Dagher G., Touzeau D.
  • Alcoholics With a History of Heroin Consumption: Clinical Features and Chronology of Substance Abuse
    Ceccanti M., Vitali M.
  • Opioid Dependence and Quality of Life: Changes in the Heroin Epidemic
    Domingo-Salvany A.
  • Predictors for Non-Relapsing in Methadone- and Buprenorphine-maintained Heroin Addicts: A Comparative Study
    Maremmani I., Pacini M., Lamanna F., Maremmani A. G. I., Pani P. P., Perugi G., Gerra G.
  • Echoing the Patient's Lack of Insight: A Role We Must Avoid Playing
    Pacini M.

 

Cover

Vol. 11 • No. 4 • December 2009

In this issue:

  • QT Interval
    Caldarola P., Cuonzo M.
  • Psychoactive Drugs and Prolongation of the QT Interval
    Deruvo G., Vendramin A., Di Sciascio G.
  • Opioid Treatment and “Long-QT Syndrome (LQTS)”: a Critical Review of the Literature
    Pacini M., Maremmani A. G. I., Dell' Osso L., Maremmani I.
  • Management of Cardiac Risk during Methadone Treatment: Focus on the QT Interval
    Pani P. P.
  • Cardiovascular Complications of Cocaine Use
    Gambarana C.

 

 

AU-CNS Associazione per l’Utilizzo delle Conoscenze Neuroscientifiche a fini Sociali
Association for the Application of Neuroscientific Knowledge to Social Aims
Via XX Settembre, 83 – 55045 PIETRASANTA (Lucca) - Italy
P. IVA 01681650469 – Codice Fiscale 94002580465
Tel/Phone: 0584 - 790073 - Fax: 0584-72081 - Email: info@heroinaddictionrelatedclinicalproblems.org
Start of page